Gene structure and expression of the mouse APOBEC-1 complementation factor: Multiple transcriptional initiation sites and a spliced variant with a premature stop translation codon

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1680, Issue 1, 2004, Pages 11-23

  Dür, Stefan ^a   Krause, Kristina ^b   Pluntke, Nina ^b   Greeve, Jobst ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

ACF ASP; APOBEC 1; Apolipoprotein B mRNA

Indexed keywords

APOBEC 1 COMPLEMENTATION FACTOR; MESSENGER RNA; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; EXON; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENE LOCATION; GENE STRUCTURE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY; LIVER; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RAT; RNA SPLICING; SMALL INTESTINE; STRUCTURE ACTIVITY RELATION; TATA BOX; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION SITE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CODON, NONSENSE; GENE EXPRESSION REGULATION; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANSCRIPTION INITIATION SITE;

EID: 4644318881     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2004.07.006     Document Type: Article

References (45)

1. P.H. Seeburg, and J. Hartner Regulation of ion channel/neurotransmitter receptor function by RNA-editing Curr. Opin. Neurobiol. 13 2003 279 283
2. B.L. Bass RNA editing by adenosine deaminases that act on RNA Ann. Rev. Biochem. 71 2002 817 846
3. S. Maas, A. Rich, and K. Nishikura A-to-I RNA editing: recent news and residual mysteries J. Biol. Chem. 278 2003 1391 1394
4. B. Teng, C.F. Burant, and N.O. Davidson Molecular cloning of an apolipoprotein B messenger RNA editing protein Science 260 1993 1816 1819
5. A. Mehta, M.T. Kinter, N.E. Sherman, and D.M. Driscoll Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA Mol. Cell. Biol. 20 2000 1846 1854
6. H. Lellek, R. Kirsten, I. Diehl, F. Apostel, F. Buck, and J. Greeve Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex J. Biol. Chem. 275 2000 19848 19856
7. S.H. Chen, G. Habib, C.Y. Yang, Z.W. Gu, B.R. Lee, S.A. Weng, S.R. Silberman, S.J. Cai, J.P. Deslypere, and M. Rosseneu Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon Science 238 1987 363 366
8. L.M. Powell, S.C. Wallis, R.J. Pease, Y.H. Edwards, T.J. Knott, and J. Scott A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine Cell 50 1987 831 840
9. J. Greeve, I. Altkemper, J.H. Dieterich, H. Greten, and E. Windler Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins J. Lipid Res. 34 1993 1367 1383
10. A. Jarmuz, A. Chester, J. Bayliss, J. Gisbourne, I. Dunham, J. Scott, and N. Navaratnam An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 Genomics 79 2002 285 296
11. T. Muto, M. Muramatsu, M. Taniwaki, K. Kinoshita, and T. Honjo Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene Genomics 68 2000 85 88
12. M. Muramatsu, K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme Cell 102 2000 553 563
13. P. Pham, R. Bransteitter, J. Petruska, and M.F. Goodman Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation Nature 424 2003 103 107
14. J. Di Noia, and M.S. Neuberger Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase Nature 419 2002 43 48
15. S.K. Petersen-Mahrt, R.S. Harris, and M.S. Neuberger AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification Nature 418 2002 99 103
16. H. Zhang, B. Yang, R.J. Pomerantz, C. Zhang, S.C. Arunachalam, and L. Gao The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Nature 424 2003 94 98
17. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424 2003 99 103
18. D. Lecossier, F. Bouchonnet, F. Clavel, and A.J. Hance Hypermutation of HIV-1 DNA in the absence of the Vif protein Science 300 2003 1112
19. X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.F. Yu Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 302 2003 1056 1060
20. M. Marin, K.M. Rose, S.L. Kozak, and D. Kabat HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat. Med. 9 2003 1398 1403
21. A.M. Sheehy, N.C. Gaddis, and M.H. Malim The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat. Med. 9 2003 1404 1407
22. R.S. Harris, S.K. Petersen-Mahrt, and M.S. Neuberger RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators Mol. Cell 10 2002 1247 1253
23. S.K. Petersen-Mahrt, and M.S. Neuberger In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1) J. Biol. Chem. 278 2003 19583 19586
24. G.S. Dance, M.P. Sowden, L. Cartegni, E. Cooper, A.R. Krainer, and H.C. Smith Two proteins essential for apolipoprotein B mRNA editing are expressed from a single gene through alternative splicing J. Biol. Chem. 277 2002 12703 12709
25. J.O. Henderson, V. Blanc, and N.O. Davidson Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene Biochim. Biophys. Acta 1522 2001 22 30
26. H. Lellek, S. Welker, I. Diehl, R. Kirsten, and J. Greeve Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker J. Biol. Chem. 277 2002 23638 23644
27. M.P. Sowden, D.M. Lehmann, X. Lin, C.O. Smith, and H.C. Smith Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing J. Biol. Chem. 279 2004 197 206
28. A. Mehta, and D.M. Driscoll Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing RNA 8 2002 69 82
29. V. Blanc, J.O. Henderson, S. Kennedy, and N.O. Davidson Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity J. Biol. Chem. 276 2001 46386 46393
30. V. Blanc, S. Kennedy, and N.O. Davidson A novel nuclear localization signal in the auxiliary domain of apobec-1 complementation factor regulates nucleocytoplasmic import and shuttling J. Biol. Chem. 278 2003 41198 41204
31. A. Chester, A. Somasekaram, M. Tzimina, A. Jarmuz, J. Gisbourne, R. O'Keefe, J. Scott, and N. Navaratnam The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay EMBO J. 22 2003 3971 3982
32. J. Greeve, H. Lellek, F. Apostel, K. Hundoegger, A. Barialai, R. Kirsten, S. Welker, and H. Greten Absence of APOBEC-1 mediated mRNA editing in human carcinomas Oncogene 18 1999 6357 6366
33. J. Greeve, A. Philipsen, K. Krause, W. Klapper, K. Heidorn, B.E. Castle, J. Janda, K.B. Marcu, and R. Parwaresch Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas Blood 101 2003 3574 3580
34. J. Greeve, D. Axelos, S. Welker, M. Schipper, and H. Greten Distinct promoters induce APOBEC-1 expression in rat liver and intestine Arterioscler. Thromb. Vasc. Biol. 18 1998 1079 1092
35. X. Qian, M.E. Balestra, and T.L. Innerarity Two distinct TATA-less promoters direct tissue-specific expression of the rat apo-B editing catalytic polypeptide 1 gene J. Biol. Chem. 272 1997 18060 18070
36. J.R. Gum Jr., J.W. Hicks, S.C. Crawley, C.M. Dahl, S.C. Yang, A.M. Roberton, and Y.S. Kim Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus J. Biol. Chem. 278 2003 49600 49609
37. T. Sakaguchi, X. Gu, H.M. Golden, E. Suh, D.B. Rhoads, and H.C. Reinecker Cloning of the human claudin-2,5′-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha J. Biol. Chem. 277 2002 21361 21370
38. I. Schmitt, B.O. Evert, H. Khazneh, T. Klockgether, and U. Wuellner The human MJD gene: genomic structure and functional characterization of the promoter region Gene 314 2003 81 88
39. W. Liu, G. Wang, and A.G. Yakovlev Identification and functional analysis of the rat caspase-3 gene promoter J. Biol. Chem. 277 2002 8273 8278
40. J. Lu, W. Lee, C. Jiang, and E.B. Keller Start site selection by Sp1 in the TATA-less human Ha-ras promoter J. Biol. Chem. 269 1994 5391 5402
41. M. Nakamuta, K. Oka, J. Krushkal, K. Kobayashi, M. Yamamoto, W.H. Li, and L. Chan Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice J. Biol. Chem. 270 1995 13042 13056
42. G. Dreyfuss, V.N. Kim, and N. Kataoka Messenger-RNA-binding proteins and the messages they carry Nat. Rev., Mol. Cell Biol. 3 2002 195 205
43. S. Yamanaka, M.E. Balestra, L.D. Ferrell, J. Fan, K.S. Arnold, S. Taylor, J.M. Taylor, and T.L. Innerarity Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals Proc. Natl. Acad. Sci. U. S. A. 92 1995 8483 8487
44. S. Yamanaka, K.S. Poksay, K.S. Arnold, and T.L. Innerarity A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme Genes Dev. 11 1997 321 333
45. S. Yamanaka, K.S. Poksay, D.M. Driscoll, and T.L. Innerarity Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif J. Biol. Chem. 271 1996 11506 11510